Search Within

Christopher A Famulare

Formats
  1. Meeting Abstract (49)
  2. Journal Article (33)
  3. Research Letter (7)
Groups
  1. Center for Hematologic Malignancies (89)
  2. Department of Medicine (86)
  3. Hematologic Malignancies, Division of (86)
  4. Adult Leukemia (84)
  5. Hematology-Oncology Fellows (63)
  6. Weinberg Fellows (59)

More Groups

People
  1. Ross Levine (48)
  2. Martin Tallman (40)
  3. Aaron Goldberg (38)
  4. Eytan Stein (31)
  5. Mikhail Roshal (28)
  6. Minal Patel (27)

More People

Years
  1. 2025 (6)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (11)
  6. 2020 (14)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (6)
  3. American Journal of Hematology (4)
  4. Cancer Discovery (4)
  5. Leukemia and Lymphoma (3)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (5)
  4. John Wiley & Sons, Inc. (4)
  5. Taylor & Francis Group (3)
  6. Cell Press (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic landscape impacts induction outcome with CPX-351 in patients with acute myeloid leukemia
    Meeting Abstract

    Talati, C.; Goldberg, A. D.; Desai, P.; Chan, O.; Famulare, C.; Komrokji, R. S.; Kuykendall, A. T.; Fernandez, H. F.; Deutsch, Y. E.; Padron, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Talati, C.; Desai, P.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Sallman, D. A.; Lancet, J. E.; Roboz, G. J.; Sweet, K. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Alisertib (MLN8237), an oral selective inhibitor of aurora kinase A, has clinical activity and restores GATA1 expression in patients with myelofibrosis
    Meeting Abstract

    Gangat, N.; Stein, B. L.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Frankfurt, O.; Altman, J. K.; Wen, J. Q.; Farnoud, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Small-molecule targeting of Musashi RNA-binding activity in acute myeloid leukemia
    Meeting Abstract

    Dinares, G. M.; Albanese, S. K.; Chow, A.; Schurer, A.; Park, S. M.; Rotsides, C. Z.; Taggart, J.; Rizzi, A.; Naden, L. N.; Chou, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
    Journal Article

    Xiao, W.; Bharadwaj, M.; Levine, M.; Farnhoud, N.; Pastore, F.; Getta, B. M.; Hultquist, A.; Famulare, C.; Medina, J. S.; Patel, M. A.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save